TGFB1 and neoplasm: MMP9 can be localized to the surface of murine mammary carcinoma cells via the hyaluronan receptor CD44 [40], as a component of tumor cell invadopodia structures [41], where it can facilitate invasion and angiogenesis by proteolytic activation of latent TGF-β [42].